BPG is committed to discovery and dissemination of knowledge
-
|
|
Homepage
|
-
|
|
Online Submission
|
- Number of total visits
-
3495338
- Number of visits today
- 1452
- Number of downloads
-
2678900
MEMBERSHIP
Cited by in F6Publishing
| Number |
Citing Articles |
| 1 |
Leicht HB, Weinig E, Mayer B, Viebahn J, Geier A, Rau M. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature. BMC Pharmacol Toxicol 2018;19:67. [PMID: 30359322 DOI: 10.1186/s40360-018-0257-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 2 |
Lin K, Zhang L, Kong M, Yang M, Chen Y, Poptic E, Hoffner M, Xu J, Tam C, Lin F. Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes. Blood Adv 2020;4:2049-57. [PMID: 32396613 DOI: 10.1182/bloodadvances.2020001690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 3 |
Singh V, Phukan UJ. Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity. Med Microbiol Immunol 2019;208:585-607. [PMID: 30483863 DOI: 10.1007/s00430-018-0573-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 4 |
Zhang L, Dai Y, Huang P, Saunders TL, Fox DA, Xu J, Lin F. Absence of complement component 3 does not prevent classical pathway-mediated hemolysis. Blood Adv 2019;3:1808-14. [PMID: 31196848 DOI: 10.1182/bloodadvances.2019031591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
